Intravenous tissue plasminogen activator, ischemic stroke, and the risk of Kounis Syndrome

被引:2
|
作者
Kounis, Nicholas G. [1 ]
Kouni, Sophia N. [1 ]
Kounis, George N. [1 ]
Kounis, Sophia A. [1 ]
机构
[1] Patras Highest Inst Educ & Technol, Dept Med Sci, Patras 26221, Greece
关键词
MYOCARDIAL-INFARCTION;
D O I
10.4103/0972-2327.85913
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:223 / U86
页数:2
相关论文
共 50 条
  • [21] Intravenous tissue plasminogen activator and stroke in the elderly
    Longstreth, W. T., Jr.
    Katz, Ronit
    Tirschwell, David L.
    Cushman, Mary
    Psaty, Bruce M.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2010, 28 (03): : 359 - 363
  • [22] Tissue plasminogen activator for acute ischemic stroke
    Qureshi, N
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (21): : 1406 - 1406
  • [23] Intravenous Thrombolysis with Recombinant Tissue-type Plasminogen Activator for Acute Ischemic Stroke in Patients with Metabolic Syndrome
    Sobolewski, Piotr
    Brola, Waldemar
    Szczuchniak, Wiktor
    Fudala, Magorzata
    Kozera, Grzegorz
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2015, 24 (08): : 1787 - 1792
  • [24] Intravenous Tissue Plasminogen Activator Therapy for an Acute Ischemic Stroke Patient with Later Diagnosed Unilateral Moyamoya Syndrome
    Yokoyama, Shota
    Manabe, Yasuhiro
    Fujii, Daiki
    Ikeda-Sakai, Yasuko
    Narai, Hisashi
    Omori, Nobuhiko
    Abe, Koji
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2013, 22 (07): : 1190 - 1192
  • [25] Predictors of Systemic Inflammatory Response Syndrome in Ischemic Stroke Undergoing Systemic Thrombolysis with Intravenous Tissue Plasminogen Activator
    Boehme, Amelia K.
    Kapoor, Niren
    Albright, Karen C.
    Lyerly, Michael J.
    Rawal, Pawan V.
    Shahripour, Reza Bavarsad
    Alvi, Muhammad
    Houston, J. Thomas
    Sisson, April
    Beasley, T. Mark
    Alexandrov, Anne W.
    Alexandrov, Andrei V.
    Miller, David W.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2014, 23 (04): : E271 - E276
  • [26] Sonothrombolysis: An effective adjunct to intravenous tissue plasminogen activator therapy in acute ischemic stroke
    Miyachi, Shigeru
    NEUROLOGY INDIA, 2017, 65 (01) : 20 - 21
  • [27] Time to Treatment With Intravenous Tissue Plasminogen Activator and Outcome From Acute Ischemic Stroke
    Saver, Jeffrey L.
    Fonarow, Gregg C.
    Smith, Eric E.
    Reeves, Mathew J.
    Grau-Sepulveda, Maria V.
    Pan, Wenqin
    Olson, DaiWai M.
    Hernandez, Adrian F.
    Peterson, Eric D.
    Schwamm, Lee H.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (23): : 2480 - 2488
  • [28] Intravenous Tissue Plasminogen Activator for Large Vessel Ischemic Stroke - Is There Still a Role? COMMENT
    Muneer, Mohamed S.
    Tawk, Rabih G.
    NEUROSURGERY, 2019, 85 : S37 - S37
  • [29] Intravenous tissue plasminogen activator treatment for ischemic stroke in dabigatran-treated patients
    Takeuchi, Satoru
    Wada, Kojiro
    Nagatani, Kimihiro
    Otani, Naoki
    Osada, Hideo
    Nawashiro, Hiroshi
    ACTA NEUROCHIRURGICA, 2012, 154 (01) : 87 - 87
  • [30] Development of orolingual angioedema in ischemic stroke patients treated with intravenous tissue plasminogen activator
    Khaja, Aslam M.
    Merrick, Michael T.
    Noser, Elizabeth A.
    Albright, Karen C.
    Gonzales, Nicole R.
    Barreto, Andrew D.
    Martin-Schild, Sheryl
    Hallevi, Hen
    Illoh, Kachikwu
    Shaltoni, Hashem M.
    Grotta, James C.
    STROKE, 2007, 38 (02) : 506 - 506